Related Experiment Video

Updated: Oct 14, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K

Therapeutic metastatic prostate cancer vaccines: lessons learnt from urologic oncology

Witold Lasek1, Łukasz Zapała2

  • 1Department of Immunology, Medical University of Warsaw, Warsaw, Poland.

Central European Journal of Urology
|November 3, 2021
PubMed
Abstract

Insights

Therapeutic cancer vaccines show promise for prostate cancer treatment. Sipuleucel-T and PROSTVAC are leading options, with potential for enhanced efficacy when combined with other therapies.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Therapeutic cancer vaccines have been a focus in oncology for decades.
  • Sipuleucel-T is the only FDA-approved cancer vaccine, targeting prostatic acid phosphatase.
  • Limited success has been achieved despite extensive research efforts.

Purpose of the Study:

  • To review advanced research on therapeutic cancer vaccines for prostate cancer.
  • To compare the most promising vaccines, sipuleucel-T and PROSTVAC.
  • To explore combination therapy strategies.

Main Methods:

  • Literature review of advanced research on therapeutic cancer vaccines.
  • Comparison of sipuleucel-T and PROSTVAC.
  • Analysis of clinical trial data for prostate cancer vaccines.

Main Results:

  • Sipuleucel-T (anti-PAP) approved in 2010.
  • Four other vaccines (GVAX, PPV, PCVAC, PROSTVAC) tested in Phase III for metastatic castration-resistant prostate cancer (mCRPC).
  • Sipuleucel-T and PROSTVAC are the most studied, currently evaluated in combination with checkpoint inhibitors.

Conclusions:

  • Combination therapy may enhance the efficacy of sipuleucel-T and PROSTVAC.
  • Further research into combination strategies is warranted.
  • Cancer vaccines represent a developing area in prostate cancer treatment.
Keywords:
PROSTVAConcoimmunologysipuleucel-Ttherapeutic cancer vaccines

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.7K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.6K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
562
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
731
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
483